Position in JAZZ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,335,787
+$5,503,182 QoQ
Shares Held
59,492
+27.3% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#110
of 640 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 65%
Shared 0%
None 35%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $144,833,314 across 62 Biotechnology names. JAZZ ranks #3 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,729 | $21,224,776 | |
| 2 | INCY |
Incyte Corp
|
168,818 | $19,137,208 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
59,492 | $14,335,787 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,953 | $11,817,953 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
17,562 | $5,551,172 | |
| 6 | ACAD |
Acadia Pharmaceuticals Inc
|
167,893 | $4,247,692 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,634 | $4,104,243 | |
| 8 | INVA |
Innoviva, Inc.
|
165,115 | $3,749,761 |
All Filings in JAZZ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,335,787 | 59,492 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,832,605 | 46,721 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | $311,048 | 2,360 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $266,042 | 2,507 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,072,780 | 8,641 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $490,752 | 3,985 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $620,441 | 5,569 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $204,814 | 1,919 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $774,661 | 6,433 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $827,421 | 6,727 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $8,004,698 | 61,841 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,930,988 | 80,108 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $14,272,588 | 97,537 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $16,256,788 | 102,045 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,061,145 | 90,488 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,059,476 | 51,660 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $237,240 | 1,524 | Shares | Sole | 2022-05-12 | |
| 2021-06-30 | $32,263,865 | 181,625 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $33,735,627 | 205,242 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $43,369,858 | 262,768 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $41,000,328 | 287,540 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $35,341,019 | 320,292 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $32,247,837 | 323,319 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||